The pig (Sus scrofa domestica) has emerged as an important large mammalian model in biomedical and pharmaceutical research [1] [2] [3] . Pigs have been widely applied for studying infectious diseases, cardiovascular disease, atherosclerosis, wound healing, diabetes, ophthalmology, cancer and cell therapies, as well as for assessing the suitability of porcine xenotransplants for humans 2, 4 . In recent years, improved methods for transgenesis have made this model even more valuable 5 . Humanized pig models include those for retinitis pigmentosa 6 , cystic fibrosis 7 , Alzheimer's disease 8 , Huntington's disease 9 , familial adenomatous polyposis 10 and immunodeficiency 11 . However, transgenesis in the pig, most commonly achieved by pronuclear DNA injection (PNI) or by SCNT, is an inefficient and expensive process, hampered by poor predictability of levels and patterns of transgene expression 2, 3, [12] [13] [14] . Gene targeting by homologous recombination is extremely inefficient in porcine somatic cells 3 , and porcine embryonic stem cells (ESCs) have not yet been established 15 . Recently, several groups described the derivation of porcine induced pluripotent cells (iPSCs) [16] [17] [18] [19] [20] ; however, only low chimerism has been found after blastocyst complementation experiments 21, 22 . The use of porcine iPSCs in the SCNT method resulted in extremely low rates of born piglets 23 .
IntroDuctIon
The pig (Sus scrofa domestica) has emerged as an important large mammalian model in biomedical and pharmaceutical research [1] [2] [3] . Pigs have been widely applied for studying infectious diseases, cardiovascular disease, atherosclerosis, wound healing, diabetes, ophthalmology, cancer and cell therapies, as well as for assessing the suitability of porcine xenotransplants for humans 2, 4 . In recent years, improved methods for transgenesis have made this model even more valuable 5 . Humanized pig models include those for retinitis pigmentosa 6 , cystic fibrosis 7 , Alzheimer's disease 8 , Huntington's disease 9 , familial adenomatous polyposis 10 and immunodeficiency 11 . However, transgenesis in the pig, most commonly achieved by pronuclear DNA injection (PNI) or by SCNT, is an inefficient and expensive process, hampered by poor predictability of levels and patterns of transgene expression 2, 3, [12] [13] [14] . Gene targeting by homologous recombination is extremely inefficient in porcine somatic cells 3 , and porcine embryonic stem cells (ESCs) have not yet been established 15 . Recently, several groups described the derivation of porcine induced pluripotent cells (iPSCs) [16] [17] [18] [19] [20] ; however, only low chimerism has been found after blastocyst complementation experiments 21, 22 . The use of porcine iPSCs in the SCNT method resulted in extremely low rates of born piglets 23 .
Germline transgenesis in pigs
PNI into porcine zygotes is inefficient (overall success rate of ~1% per treated embryos) and cumbersome. In contrast to rodent species, porcine zygotes are opaque, and the pronuclei are not readily visible. To visualize porcine pronuclei, a high-speed centrifugation (12,000-15,000g ) is required, which may have a negative effect on embryonic development. Successful injection of foreign DNA into a porcine pronucleus requires experienced technical skills, and it results in a high ratio of lysed zygotes owing to the particular vulnerability of the pronuclei. SCNT is currently the most commonly applied method for porcine transgenesis. The procedure includes gene transfer into primary somatic cells, screening of cells carrying the desired genetic modification, introduction of a genetically modified cell into an enucleated porcine oocyte and activation of the reconstructed embryo to initiate cleavage divisions 3, 7, 8 . The transfer of >100 reconstructed embryos to one surrogate animal is required to establish pregnancy in the pig 7, 8 , and success rates of only 1-3% (per reconstructed embryos) have been achieved 7, 8 . Furthermore, SCNT protocols are associated with a high workload, and partial genome reprogramming during SCNT commonly results in high rates of abortion and neonatal deaths.
In addition to PNI and SCNT, lentiviral transduction of zygotes 24, 25 and intracytoplasmatic sperm injection 26, 27 have been used for transgenesis in the pig. Lentiviral transduction can produce high ratios of transgenic offspring (20-30% transgenic offspring per treated embryos), but this technique frequently results in cell mosaicism and thus reduced germline transmission; the maximal cargo of foreign DNA with lentiviral vectors is ~7 kbp; and epigenetic silencing of the virally integrated constructs has been observed 13 . Another limitation is that a laboratory with biosafety level 2 is required for lentivirus production and handling. Intracytoplasmatic sperm injection (ICSI) of membranedamaged (dead) spermatozoa incubated with foreign DNA has been used to produce transgenic piglets; however, this method is technically demanding and the reported success rates are low (fewer than 1% transgenic offspring per treated oocytes) 26 . the transposase and the transposon are provided separately to allow controlled transposition. In such a bi-component vector system, a DNA sequence of interest (here, a transgene) can be cloned in place of the original transposase gene between the transposon ITRs, and it can be mobilized by supplementing the transposase enzyme in trans as an expression plasmid or as in vitro-synthesized mRNA (Fig. 1a) . During transposition, the transposase excises the transposon from its donor plasmid and integrates it into a chromosomal locus (Fig. 1b) . On the basis of fossil record of transposons that were active >10 million years ago in fish genomes, an ancient transposon was 'awakened' (molecularly reconstructed) and named SB after the Grimm brothers' fairy tale 28 . SB was the first transposon that was shown to be capable of efficient transposition in vertebrate cells, thereby opening new avenues for genetic engineering in animal models (reviewed in ref. 29) . In addition to SB, the piggyBac and Tol2 transposons have also been developed for use in transgenic procedures 29 .
The SB system combines the advantages of retroviral vectorspermanent gene insertion into recipient genomes-with those of naked DNA molecules; simple and safe production and application. Because transposition is a cut-and-paste mechanism that does not involve reverse transcription, transposon-based vectors can tolerate larger and more complex transgenes, and the SB system is not strictly limited by the size of expression cassettes 30 . Indeed, inserts as large as bacterial artificial chromosomes were recently shown to transpose with SB at reasonable efficiencies in mouse ESCs 31 . When performing transgenesis, a single-copy transgene insertion, which is not disturbing endogenous gene functions, is desirable. Chromosomal integration of SB transposons is nearly random at the genome level, resulting in ~60% of the SB transposon integrations being intergenic [32] [33] [34] [35] . Furthermore, transposons have been shown to efficiently deliver a wide variety of transgene cassettes (reviewed in refs. 29, 36, 37) .
Because the transposase is only transiently present in the cell, the integrated transposable element is stable (i.e., it will not undergo further rounds of transposition), thereby rendering transposons easily controllable, conditional DNA delivery tools that can be used for versatile applications, including germline gene transfer. We have recently developed a hyperactive variant of the SB transposase, called SB100X, by in vitro evolution 38 . SB100X supports efficient germline transgenesis in mice [38] [39] [40] , rats 39, 40 , rabbits 39, 41 and pigs 42 . We optimized the SB100X-mediated protocol by carefully titrating the relative amounts of transposase and transposon to obtain optimal rates of transgenesis to generate founders, and extensively evaluated it for efficacy, toxicity, mosaicism, germline transmission, insertion site preferences, transgene copy number and silencing. One of the most important aspects of using this protocol is that no major mosaicism was observed, and transgene expression was maintained for several generations in all species tested. This lack of mosaicism is in sharp contrast to current PNI or viral approaches to transgenesis. This is probably because of the very nature of transgene integration: transposition results in precise (i.e., the ends of the integrating DNA are well defined) genomic integration of monomeric transgene units within a short time frame after administration. Furthermore, unlike retroviral vectors [43] [44] [45] [46] , SB100X transposase-catalyzed transgene integration does not seem to trigger transcriptional silencing 34, 39 . Importantly, SB transposon-tagged genomic loci are suitable for recombinase-mediated cassette exchange (RMCE) 47 , allowing targeted genome engineering 5, 42 .
Transposase-catalyzed DNA integration seems to favor transcriptionally permissive loci, and all transgenic pigs that we have examined, from the founder to the F 2 generation, showed the expected expression patterns 42, 48 . Thus, transpositionmediated transgenesis compares favorably to current alternatives, particularly if the overall success rates of 6-8% (transgenic animals with desired phenotype per treated zygotes) and the success rates of 40-60% of transgenic founders per born animals are taken into account. The application of the SB transposon system described here will markedly enhance the porcine genomic toolbox, and it is expected to be adaptable to other farm animal species, including cattle.
Limitations
DNA transposons, including SB, are regulated by overproduction inhibition, which means that overexpression of the transposase has a negative effect on transposition 34, 49 . The practical consequence of this phenomenon is that an optimal ratio of transposon donor plasmid and transposase mRNA needs to be established. As a rule of thumb, the injection mixture should contain 10 ng/µl transposon and 5 ng/µl transposase plasmids for an SB vector of a total size of ~6.1 kb containing an ~2.5-kb transgene cassette 38 . For larger transgenes, the concentration of the donor plasmid in the microinjection mixture has to be increased to maintain optimal molar ratios between transposon and transposase.
Although transposition in ovo does not allow prescreening for potential transgenics, the high ratio of transgenic offspring compensates for this limitation. As an alternative to the direct embryo injection described here, both the SB 50-52 and the piggyBac 53 The transposon carrying a GOI is excised from the donor plasmid, and it is integrated at a chromosomal site by the transposase (purple spheres). This figure is reproduced from ref. 40. modify porcine cells in vitro, which were subsequently used as donors in SCNT for pig transgenesis.
Experimental design
We provide a comprehensive protocol for the generation of germline transgenic pigs. We describe the use of SB transposon vectors, animal breeding protocols, cytoplasmic microinjection to introduce plasmids into fertilized oocytes and PCR-based genotyping protocols for the identification of transgenic animals.
The generation of transgenic pigs is achieved through the coinjection of a vector carrying a gene of interest (GOI) cloned between the ITRs of SB and an expression vector that produces the transposase (Fig. 1) into the cytoplasm of a zygote 5, 42 . Cytoplasmic injection (CPI) (Fig. 2a,b) is a relatively gentle injection method that avoids high-speed centrifugation of porcine zygotes and invasive removal of metaphase plates from porcine oocytes, which is an essential step of SCNT. The developmental competence of mammalian zygotes is not, or only minimally, affected by CPI 54, 55 , thus allowing for the reduction of animal numbers used. The protocol consists of the following major parts:
Preparation of plasmids for microinjection (Steps 1-7). These steps include molecular cloning of a GOI into SB transposon vectors and purification of the plasmids, as well as preparing a mixture consisting of the purified transposon plasmid and the plasmid that expresses the transposase. One useful way to detect transgene integration and expression is to use a fluorescent reporter protein, such as Venus, which is an optimized (brighter) derivative of the enhanced yellow fluorescent protein.
We have previously demonstrated that an SB transposon carrying a CAGGS (CMV enhancer, chicken β-actin promoter)-driven Venus transgene (pT2-RMCE-Venus) facilitates the detection of transgenic animals 38, 39, 48 .
Transgenesis with SB in pigs (Steps 8-79). These steps include superovulation of sows and collection of zygotes, microinjection of the plasmid mixture into zygotes, surgical embryo transfer (ET) to recipient sows followed by after-care of recipient animals and ultrasound scanning for implantations. To set up the CPI method, it may be helpful to start with in vitro culture of microinjected embryos to allow the assessment of ratios of successful injections and viable embryos 54 . In vitro culture for 5 d should lead to the development of blastocyst stages, consisting of an inner cell mass, the trophoblast and a central, fluid-filled cavity 54 . The Venus transposon allows a direct assessment of successfully injected embryos by fluorescence microscopy. In addition, mock injections of zygotes with buffer or nontransposon plasmids can be performed as controls. However, owing to the scarcity of porcine zygotes, it is recommended to perform the injections only with the transposon plasmids mix. Finally, phenotyping and imaging of Venus-expressing transgenic pigs are described.
Genotyping of transgenic animals (Steps 80-106).
These steps include PCR-based analysis of F 0 and F 1 offspring to establish founders and germline transmission. A simple, quick PCR test can be applied to determine the presence of integrated transposon sequences from genomic DNA samples. The PCR primers amplify sequences in the left ITR of SB; thus, this protocol can be universally applied irrespective of the GOI that was cloned in the SB vector. To assess copy numbers of integrated transposons and to map the genomic integration sites, a ligation-mediated PCR (LMPCR) procedure is applied 56 . The procedure consists of a restriction enzyme digest of the genomic DNA, ligation of an oligonucleotide adapter to the ends of the fragmented DNA, PCR amplification of a transgene/genomic DNA junction in two rounds of nested PCR with primers specific to the adapter and to the ITRs of the SB transposon, and sequencing of the junctions to map the insertion to the reference genome 57 . Finally, a locusspecific PCR is applied to distinguish and track the individual integrations in the F 1 and later generations.
Another issue to consider is the level of expertise needed to implement the protocol. The protocol requires access to pig animal quarters equipped with a surgical room. The animal caretaker must be trained in methods of reproductive biology, animal welfare and dealing with genetically modified organisms. For surgical ET, a surgical team consisting of a surgeon, a technician for sterile assistance, a technician for nonsterile assistance, a technician for anesthesia and a technician for pre-and postoperative care of the animals are required. 3 , 2.383 g of HEPES, 1.8667 g of sodium lactate, 0.06 g of penicillin (100 U/ml) and 0.05 g of streptomycin (50 µg/ml) in 900 ml of ultrapure water. Adjust the pH to 7.34 and the volume to 1 liter with water. After sterile filtration, store 100-ml aliquots at 4 °C for up to 3 months. Sodium pyruvate, 100 mM Dissolve 11 g of sodium pyruvate in 1 liter of ultrapure water to obtain a 100 mM solution. Sterilize the solution by filtration and store it at 4 °C for up to 3 months. HEPES+calcium working medium Warm a 100-ml aliquot of the HEPES+calcium stock medium to room temperature (21 °C) directly before use; add 250 µl of 100 mM sodium pyruvate, 1.056 g of sucrose and 0.4 g of BSA, and then dissolve by stirring. The HEPES+calcium working medium needs to be freshly prepared. Hyaluronidase stock solution Dissolve 50 mg of hyaluronidase in 1 ml of HEPES+calcium stock medium to obtain a 5% (wt/vol) stock solution. Store the solution frozen in 50-µl aliquots at −20 °C for up to 6 months.
•
To obtain a 0.125% (wt/vol) hyaluronidase working solution, thaw a 50-µl aliquot and dilute it to 2 ml with HEPES+calcium working medium. proceDure preparation of plasmids for microinjection • tIMInG 2-8 weeks  crItIcal Plasmids for CPI must be of high purity, and they should be prepared by good laboratory practices to avoid co-purification of bacterial genomic DNA, RNA or endotoxins. The A 260 /A 280 ratio (as measured by spectrophotometry) of the purified DNA should be between 1.8 and 2.0, and the A 260 /A 230 ratio should be between 2.2 and 2.4; otherwise, the plasmid DNA should be discarded. 1| Clone your GOI between the ITRs of an SB transposon donor plasmid by standard molecular cloning procedures (http://www.protocol-online.org/).
2|
Transform the plasmids (the transgene-containing plasmid from Step 1 and pCMV(CAT)T7-SB100X) into DH5α bacteria, and isolate DNAs with the plasmid maxi kit according to the manufacturer's instructions.
3|
Adjust the plasmid DNA concentrations to 1 µg/µl in a total volume of 100 µl.
4|
Precipitate the plasmids by adding 10 µl (a one-tenth volume) of 4 M LiCl and 250 µl (2.5 volumes) of 2-propanol to 100 µl of plasmid solution, and by mixing and freezing them at −80 °C for 1 h.
5|
Centrifuge the mixture at 12,000g for 30 min at 4 °C, wash the pellet in 70% (vol/vol) ethanol, discard the ethanol and air-dry it at room temperature for 10 min.
6|
Resuspend the pellet in 100 µl of ultrapure H 2 O and determine the DNA concentration in a NanoDrop spectrophotometer.
7|
Confirm supercoiled conformation and purity of the plasmids by agarose gel electrophoresis (Fig. 2c) : digest 4 µg of plasmid DNA with a restriction enzyme that is predicted to cut the plasmid only once (http://protocol-online.org), and run the DNA on a 0.7% (wt/vol) agarose gel. In parallel, load 4 µg of undigested plasmid. The undigested plasmid should mainly consist of a supercoiled band and a weak band indicating nicked plasmids. The digested (linearized) plasmid should run at the calculated size. The absence of high-molecular-weight DNA confirms the lack of contamination of the sample by bacterial genomic DNA (Fig. 2c) .  pause poInt Plasmids can be stored at −20 °C for up to 1 year. (Fig. 3) . Cage the sows individually and add 4 ml of Regu-Mate to the morning fodder for 14 d (Fig. 3) .
9|
Inject the donor sows with 1,500 I.U. PMSG i.m. 1 d after completion of Regu-Mate feeding or, in case no Regu-Mate feeding was required, 4 d before the calculated insemination time ( Fig. 3 ; day 0) at 9:00.
10|
Inject the donor animals with 500 I.U. hCG i.m. at 9:00 3 d after the PMSG injection.
11|
Check the animals for signs of estrus, such as swollen and reddened vulva, 1 d after hCG injection.
12|
Inseminate sows of the donor group with semen ordered from a commercial supplier; alternatively, semen samples can be obtained from trained boars housed at a boar center by the gloved hand technique. Dilute the sperm-rich fraction with prewarmed (37 °C) Androhep (1:1). Determine sperm counts under a microscope with a 100× objective.
13|
Dilute semen with Androhep to a final concentration of 10 8 sperm cells per ml, and then fill a QuickTip Flexitube with 100 ml of this semen solution.
14|
Artificially inseminate the donor sows 24 h after hCG injection for the first time (Fig. 3 ) and 8 h later for the second time, by using a conventional insemination catheter 15| Kill the zygote donor sows 24 h after the first insemination.
16|
Excise the urogenital tract, and transport them to the laboratory in an insulated thermo-container.
17|
Dissect the oviducts from the ovaries and uterus (Fig. 4a) .
18|
Examine the ovaries and count the ruptured follicles to estimate the number of zygotes in the oviduct (Fig. 4b) . About 60-150 zygotes can be expected to be obtained from five donors. ? trouBlesHootInG 19| Flush the oviducts from the infundibulum tubae uterinae by using a 10-ml syringe with a buttoned cannula (diameter 1.4 mm) twice with prewarmed (37 °C) 1% (vol/vol) NCBS solution into a Petri dish (diameter 90 mm) (Fig. 4c-e) .
20|
Repeat the flushing (Step 19) with 10 ml of 1% (vol/vol) NCBS solution.
21|
Screen the collected flushing fluid for the presence of zygotes under a stereomicroscope. Porcine zygotes have a diameter of 120 µm; they are coated with a zona pellucida, and appear dark-colored ( Fig. 2a; (Fig. 3) . As recipients of microinjected zygotes, three sows at the age of 8 months are needed. The three animals need to be separated from each other to make sure that they all get their individual dose of Regu-Mate.  crItIcal step Choose animals that have undergone at least one cycle of natural heat. 29| Assemble the left (holding) micromanipulator by connecting the holding pipette with soft tubing to a 1-ml syringe.
30| Back-fill the injection pipette with the plasmid solution prepared in Step 27.
31| Connect the injection pipette to the Eppendorf transjector and fix it on the right (injection) micromanipulator.
32| Add 500 µl of 1% (vol/vol) NCBS on the siliconized glass plate.
33|
Break the tip of the injection pipette by moving it quickly against the siliconized glass plate.
34|
Heat up the microscope stage to 34 °C. This temperature is recommended to reduce evaporation. Porcine zygotes tolerate this temperature well for short periods (~5 min); depending on the skills of the experimenter, 5-15 zygotes can be injected within this time.
35|
Adjust the holding pipette on the siliconized glass plate in a 500-µl droplet of 1% (vol/vol) NCBS solution.
36| Place up to ten zygotes (from Step 23) with a transport pipette in the 1% (vol/vol) NCBS drop.
37|
Fix one zygote at the tip of the holding pipette (Fig. 2a) by applying gentle suction with the connected 1-ml syringe. Use a 20× magnification.
38|
Use the joystick control of the Eppendorf transjector to move the tip of the injection pipette close to the equatorial zone of the fixed zygote (opposite to the holding pipette). Use ×40 magnification.
39|
Push the injection pipette through the zona pellucida and the plasma membrane (Fig. 2a,b) .
40| Microinject the plasmid solution (
Step 27) directly into the opaque cytoplasm. Apply an injection pressure between 0.5 and 0.8 hPa, depending on the opening size of the injection pipette. The injection pressure can be set at the Eppendorf transjector. An estimated volume of 10 pl of plasmid solution is injected by this procedure.  crItIcal step Change the drop of 1% (vol/vol) NCBS on the glass plate every 15 min to avoid concentration by evaporation.  crItIcal step Change the injection pipette if the tip gets dirty, or if it is clogged with remnants of cytoplasm or cell membrane.
41|
After all zygotes of a group have been injected, transfer them to a drop of HEPES+calcium medium covered with silicone oil, and store them at 39 °C for up to 3 h. Typically, the injection of ~90-120 zygotes will take 2-3 h. This step can be completed by 13:00 on the injection day. Check the zygotes 15 min before ET to surrogates sows for signs of lysis-up to 20% of the injected zygotes may lyse after being injected, and they are to be discarded. Lysed zygotes show an uneven cell membrane, and the cytoplasm may leak out of the injection site.
42|
Load each transfer straw with 30-40 zygotes, sufficient for ET into one recipient. Place only intact zygotes in the transfer straw. Load the transfer straw as follows: medium → air→ medium with zygotes → air → medium (Fig. 5) .
43| Transport the transfer straws to the surgery room in a portable incubator at 39 °C. 45| Assess Venus expression in blastomeres at day 5 of culture with a fluorescence microscope.  crItIcal step Expression of the Venus reporter in blastocysts is a good indicator for gene transfer, but it is alone no proof of SB-catalyzed transposition, as episomal plasmids will also be transcribed 54, 55 . To prove integration, ET to surrogates and the analysis of offspring is recommended.
et into synchronized surrogates
• tIMInG 2 h 46| Fast the surrogate sows for at least 12 h before surgery with access to water. Do not feed the surrogates on the day of surgery.
47|
Weigh the animals at around 14:00 on the day of microinjection and surgery, to allow calculation of the dose of anesthetics.
48|
Treat the sows with azaperon (1 mg/kg i.m. = 1 ml/40 kg body weight) 45 min before surgery.
49| Place a venous access in an ear vein, and anesthesize the sow i.v. with ursotamin (10 mg/kg = 1 ml/10 kg) and metamizol (50 mg/kg = 1 ml/10 kg).
50|
Place and fix the anesthetized animal in a dorsal position on a surgery table.
51| After washing and cleaning the sow, sterilize the skin with 70% (vol/vol) ethanol.
52|
Cover the surgery field with an adhesive foil to ensure sterile conditions.
53|
Cut the skin with a scalpel at the linea alba at a length of ~10-12 cm; further handling is done by manual preparation by the surgeon and the sterile assistant by wearing sterile surgical gloves.
54|
Gently move away the intestines to allow access to one uterus horn.
55|
Gently pull out one uterus horn.
56|
Examine the connected ovary for the presence of ovulated follicles (Fig. 6a,b) . If the ovary contains more than five ovulated follicles, this side is used for ET. If fewer than five ovulation sites are counted, pull out the other uterus and inspect the ovary. If this ovary also has fewer than five ovulation sites, the animal is not used for ET. If five or more ovulated follicles are counted, the ET is continued.
57|
Take out the transfer straw from the portable incubator (Step 43).
58|
Carefully insert the soft transfer straw through the infundibulum into the oviduct (Figs. 5c,d and 6b) .
59| Flush the embryos into the oviduct by applying slight pressure with a mandrin (Figs. 5d and 6c) . Care has to be taken to avoid injuries to the infundibulum, and bleedings.
60|
Pull out the transfer straw, and gently place back the uterus horn.
61|
Dampen the uterus with 50-100 ml of sterile, prewarmed (37 °C) PBS to avoid bonding. 62| Stitch the wound in three layers (Fig. 6d) and cover it with duct tape.
63| Finally, inject the sow i.m. with Procapen (20 mg/kg) and transport it back into the animal quarters.
64|
Examine the animals every hour until they stand up.
confirming the establishment of a pregnancy • tIMInG 30 min 65| Starting from day 25 after ET, inspect the recipient sows by ultrasound (Fig. 6e) for implantation and developing fetuses. Depending on the purpose of the experiment, pregnant recipients can be killed to obtain fetuses of different developmental stages, or they can be allowed to give birth. ? trouBlesHootInG 66| Check the surrogates daily for symptoms of natural heat (swollen and reddened vulva), which may indicate that the transferred embryos have been resorbed. establishment of transgenic pig lines • tIMInG 10-12 months ! cautIon All F 0 animals and all of their offspring are, by definition, putative gene-modified organisms (GMOs). It must be ensured that the pigs are maintained in a registered biosafety level 1 (S1) animal facility and that the animals and their fate are documented.  crItIcal Breeding to homozygous transgenic lines often causes inbreeding problems in pigs, such as extremely small litters of 1-3 pups. Therefore, it is advisable to maintain desired transgenes in hemizygous lines. 67| Pregnancy and delivery. Pregnancy in pigs lasts for 115-117 d. In the last week of gestation, cage the sows individually and inspect them daily for signs of birth, i.e., swelling and reddening of the vulva, as well as milk production in the mammary glands.
68|
Allow the sows to give birth spontaneously, which typically occurs during nighttime. ? trouBlesHootInG 69| Check sows during delivery, because in the case of a small litter size (2-4 piglets) the birth process may stop or may be delayed.
70|
If the time interval between delivered piglets is longer than 30 min, an i.m. injection of oxytocin (10-30 U per sow) is recommended; otherwise, piglets may die in the uterine channel from suffocation.
71|
Check whether the afterbirth is coming on time (within the next 16 h); otherwise, another oxytocin treatment is recommended. 73| If the sow is nervous and did not lie down, an injection (i.m.) of azaperon (0.2 mg/kg) is recommended. This will calm down the sow and allow the piglets to suckle colostrum.  crItIcal step It is important that all piglets suck colostrum milk. Small or weak piglets may require hand feeding with colostrum before they start suckling themselves. Colostrum is important to support the piglets with maternal antibodies, as the epitheliochorial organization of the porcine placenta effectively prevents any transfer of antibodies.
74|
If permanent hand feeding is required, keep the piglet(s) in a small box below an IR warming bulb.
75|
Feed the piglets at 4-h intervals with 50-200 ml of prewarmed milk replacement (volume depends on age and size). At the age of 3 weeks, they will start grabbing solid pellets.
76|
Administer iron injections to all piglets (1 ml of Mediferan per animal, i.m.) on the second day.
77|
For detection of fluorescence, collect the piglets in a small box and transport them into a dimmed room.  crItIcal step To avoid false-positive detections and to set up the system, it is important to compare transgenic piglets expressing the fluorescent marker with nontransgenic littermates (alternatively, age-matched wild-type piglets). This allows for the assessment of the amount of scattered and reflected light.
78|
Excite the piglets with a blue floodlight LED and identify the fluorescent piglets by using goggles with specific emission filters (Fig. 7a,b) . Images and videos can be obtained by using an electronic camera equipped with the proper emission filter (supplementary Video 1). 79| Hair phenotyping (optional). Collect hair samples for fluorescence analysis under a microscope 59 . In transgenic pigs carrying the CAGGS-Venus transposon, the Venus protein is deposited in the hair and maintains its fluorescent properties. The hair samples can be stored under ambient conditions (e.g., in Petri dishes) without loss of fluorescence for more than 6 months. Genotyping by Southern blotting can be performed to determine the copy number of genomically integrated transposons (Fig. 7c,d ) 42 . The expression pattern can be confirmed by western blotting with a transgene-specific antibody (Fig. 7e,f) 59 . . 1b) , in 50-µl volumes. Include a negative control sample (genomic DNA isolated from a nontransgenic animal) as well. Follow the instructions of the enzyme supplier. To reach complete digestion, incubate the reaction for 3 h at 37 °C.  crItIcal step Always use high-quality genomic DNA as template for genotyping PCR. Good-quality genomic DNA runs on an agarose gel as a dominant, high-molecular-weight band (supplementary Fig. 1c) .
Genotyping of transgenic animals

96|
Place the tubes containing the oligonucleotide solutions into a boiling water bath for 2 min, switch off the heating and leave the tubes in the bath overnight to allow slow cool-down and hybridization of the two single-stranded oligonucleotides to form the double-stranded linker.  pause poInt The annealed double-stranded oligonucleotides can be stored at −20 °C for up to 1 year.
97|
Ligate the BfaI linkers and the DpnII linkers to the corresponding BfaI-and DpnII-digested genomic DNA samples, respectively (supplementary Fig. 1b) . Set up the ligation reaction containing the components below, and incubate them overnight at 16 °C. The 'X' indicates that the amount will vary according to the concentration. 
103|
If strong, distinct bands are visible, isolate them from the gel by using the QIAquick gel extraction kit according to the manufacturer's instructions, and then sequence them. Multiple bands often represent multiple insertions, and lower-intensity bands may represent mosaic integrations, all of which need to be isolated from the gel, subcloned and sequenced. One should be able to identify the TA target dinucleotides immediately flanking the ITR in the genomic sequence, the BfaI and/or DpnII recognition sites and the linkers that had been ligated to the DNA ends. The PCR amplifications applied in parallel on the BfaI-and DpnII-digested DNA methods help the user recover all integrations.
104| Map the insertion sites by a BLAT or BLAST search of the DNA sequence directly flanking the transposon, either at the UCSC Genome Bioinformatics website (http://genome.ucsc.edu/cgi-bin/hgBlat) or at the NCBI website (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
tracking individual transgene integrations by locus-specific pcr • tIMInG 1 week 105| Design primers matching the integration loci mapped in the founder animals (Step 104). Avoid designing primers that would bind to repetitive elements and thus amplify nonspecific PCR products. The BLAT search at the UCSC Genome Bioinformatics website directly provides a RepeatMasker annotation of the genomic loci where the SB transposons have integrated. When using BLAST at the NCBI website, select 'map viewer' for a given BLAST hit, then select 'maps & options' and choose 'repeats' to see the RepeatMasker annotation. After identification of a genomic region free of repetitive sequences in the neighborhood of the SB ITR, design the locus-specific primer so that its T m is between 55 and 60 °C, and its length is between 20 and 25 nt. Run a BLAT or BLAST search with the new primer sequences to make sure that they do not bind to other genomic locations. In addition, general rules for PCR primer design can be found, for example, at http://www.premierbiosoft.com/tech_notes/PCR_Primer_Design.html.
106|
Perform the locus-specific PCR with the primer designed in Step 105 and primer Tbal (table 1) to trace specific transgene integrations by the presence or absence of an amplified product. To maximize the specificity of the primer annealing to the genomic target, the use of touchdown PCR is recommended, which consists of 5-10 touchdown cycles in which the annealing temperature is decreased stepwise by 1 °C per cycle down to the final annealing temperature, at ~2 °C below the T m of the lower T m primer, and 25 additional standard cycles. supplementary Figure 2 shows an example of locus-specific PCR test of a rat founder and its F 1 descendants.
? trouBlesHootInG Troubleshooting advice can be found in table 2.
• tIMInG Steps 1-7, preparation of plasmids for microinjection: 
